Why it was recalled
CGMP Deviations
Product description
CSF-HC Otic Insufflation Capsule, Sulfacetamide Sodium/Ciprofloxacin/Hydrocortisone/Amphotericin B Otic Powder, 50mg/ 30mg/ 25mg/ 5mg, 5 count bottle, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1634-01
Lot numbers, UPCs & expiration codes
10-2021-05@9 01-01-2022 & 10-2021-28@4 01-26-2022
Where it was sold
nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0432-2022
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Dec 6, 2021
- FDA report date
- Feb 2, 2022
- Quantity
- 440 cartons
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Edge Pharma, LLC
Original FDA data
Every field from FDA enforcement report D-0432-2022, exactly as published.
Show all FDA fields
- City
- Colchester
- State
- VT
- Status
- Terminated
- Country
- United States
- Event ID
- 89172
- Address
- 856 Hercules Dr
- Code information
- 10-2021-05@9 01-01-2022 & 10-2021-28@4 01-26-2022
- Postal code
- 05446-8014
- Report date
- Feb 2, 2022
- Product type
- Drugs
- Recall number
- D-0432-2022
- Classification
- Class II
- Recalling firm
- Edge Pharma, LLC
- Product quantity
- 440 cartons
- Termination date
- Jun 7, 2023
- Reason for recall
- CGMP Deviations
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- CSF-HC Otic Insufflation Capsule, Sulfacetamide Sodium/Ciprofloxacin/Hydrocortisone/Amphotericin B Otic Powder, 50mg/ 30mg/ 25mg/ 5mg, 5 count bottle, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1634-01
- Distribution pattern
- nationwide
- Recall initiation date
- Dec 6, 2021
- Initial firm notification
- Press Release
- Center classification date
- Jan 24, 2022